Each year in February Ovarian Cancer Australia runs a national Ovarian Cancer Awareness Month campaign to highlight the symptoms of ovarian cancer and to raise funds for our programs.
About us
Dr Linda Mileshkin
Medical Oncologist, Peter MacCallum Cancer Centre, Melbourne
Dr Mileshkin is a consultant medical oncologist at the Peter MacCallum Cancer Centre and the Mercy Hospital for Women and has a particular interest in the treatment of gynaecological cancers.
She is involved in multiple clinical research projects related to early and late phase studies of novel therapies for cancer and is an Associate Director for Cancer Trials Australia, and a member of the Board and Research Advisory Committee of the Australia New Zealand Gynecological Oncology Group (ANZGOG).
She has expertise in running phase 1-3 trials, as well as the development and successful completion of several investigator-initiated phase II trials. Most recently she has made significant progress in the development and initiation of a cooperative group international phase III trial testing the role of adjuvant chemotherapy for cervical cancer.
She also has a particular interest in the supportive care of patients with cancer and is currently working on a number of projects in this area.
Ovarian Cancer Awareness Month - February

Upcoming Events
-
Our Research, Your Future forum - Friday 25 May
Ovarian Cancer Australia and the Prostate Cancer Foundation of Australia invite our supporters and members to a...
Learn more -
Mother's Day - Our ambassadors share their thoughts...
This year we’re celebrating Mother’s Day by asking everyone to send a K.I.S.S. to all the mums they...
Learn more -
Working Beyond Cancer Workshop - 2 June 2012
Free Cancer Council NSW Workshop Saturday 2nd June 2012 Location: North SydneyTime: 9am – 3.30pmHave you...
Learn more
Awareness
Personal Story
It all began with a constant niggling pain in my right groin area. In December 2006 I went to...
Featured News
An Australian-led clinical trial has identified a promising treatment for ovarian cancer. The...